Literature DB >> 21647708

Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.

Hui Xie1, Yi-Xue Xue, Li-Bo Liu, Yun-Hui Liu, Ping Wang.   

Abstract

The purpose of the present study was to determine the potential for RhoA/ROCK signaling to play a role in endothelial-monocyte-activating polypeptide (EMAP) II-induced increase in blood-tumor barrier (BTB) permeability in rat brain microvascular endothelial cells (RBMECs). In the present study, we used an in vitro BTB model, a RhoA inhibitor (C3 exoenzyme) and a ROCK inhibitor (Y27632) to determine whether RhoA/ROCK pathway play a role in the process of TJ disassembly, stress fiber formation, MLC and cofilin phosphorylation, as well as increase of BTB permeability induced by EMAP II. The results revealed that BTB permeability was increased by EMAP II induction, and C3 exoenzyme or Y27632 could partially inhibit the EMAP II-induced increase of BTB permeability. The significant down-regulations in tight junction (TJ)-associated proteins occludin, claudin-5 and ZO-1 and stress fiber formation by EMAP II administration were observed, which were partly prevented by C3 exoenzyme or Y27632 pretreatment. Moreover, the significant increases in RhoA activity, myosin light chain (MLC) and cofilin phosphorylation by EMAP II administration were observed, MLC and cofilin phosphorylation were partly inhibited by C3 exoenzyme or Y27632 pretreatment. The present study demonstrates that the activation of RhoA/ROCK signaling in RBMECs was required for the increase of BTB permeability and these effects are related with the ability for RhoA/ROCK to mediate TJ disassembly and stress fiber formation by phosphorylating cofilin and MLC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647708     DOI: 10.1007/s12031-011-9564-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  47 in total

1.  Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin.

Authors:  Susan M Keezer; Susan E Ivie; Henry C Krutzsch; Anita Tandle; Steven K Libutti; David D Roberts
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 2.  Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

Authors:  E Marleen Kemper; Willem Boogerd; Ingrid Thuis; Jos H Beijnen; Olaf van Tellingen
Journal:  Cancer Treat Rev       Date:  2004-08       Impact factor: 12.111

Review 3.  Rho as a regulator of the cytoskeleton.

Authors:  Y Takai; T Sasaki; K Tanaka; H Nakanishi
Journal:  Trends Biochem Sci       Date:  1995-06       Impact factor: 13.807

4.  Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase.

Authors:  M Amano; K Chihara; K Kimura; Y Fukata; N Nakamura; Y Matsuura; K Kaibuchi
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

5.  Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.

Authors:  Anita T Tandle; Chiara Mazzanti; H Richard Alexander; David D Roberts; Steven K Libutti
Journal:  Cytokine       Date:  2005-04-07       Impact factor: 3.861

6.  Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.

Authors:  Donald Wong; Katerina Dorovini-Zis; Steven R Vincent
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

7.  Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.

Authors:  Hui Xie; Yi-Xue Xue; Li-Bo Liu; Yun-Hui Liu
Journal:  Brain Res       Date:  2010-01-18       Impact factor: 3.252

8.  RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability.

Authors:  Dolly Mehta; Gias U Ahmmed; Biman C Paria; Michael Holinstat; Tatyana Voyno-Yasenetskaya; Chinnaswamy Tiruppathi; Richard D Minshall; Asrar B Malik
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

9.  Growth of brain microvessel endothelial cells on collagen gels: applications to the study of blood-brain barrier physiology and CNS inflammation.

Authors:  D Biegel; J S Pachter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-09       Impact factor: 2.416

10.  Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex.

Authors:  Andrei I Ivanov; Ingrid C McCall; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

View more
  23 in total

1.  Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.

Authors:  Zhen Li; Xiao-Bai Liu; Yun-Hui Liu; Yi-Xue Xue; Jing Liu; Hao Teng; Zhuo Xi; Yi-Long Yao
Journal:  J Mol Neurosci       Date:  2015-10-31       Impact factor: 3.444

2.  Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.

Authors:  Zhen Li; Yun-hui Liu; Yi-xue Xue; Li-bo Liu; Ping Wang
Journal:  J Mol Neurosci       Date:  2012-04-25       Impact factor: 3.444

Review 3.  Regulation of paracellular permeability: factors and mechanisms.

Authors:  Yan-Jun Hu; Yi-Dong Wang; Fu-Qing Tan; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

4.  Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.

Authors:  Zhen Li; Xiao-Bai Liu; Yun-Hui Liu; Yi-Xue Xue; Ping Wang; Li-Bo Liu; Yi-Long Yao; Jun Ma
Journal:  J Mol Neurosci       Date:  2015-06-05       Impact factor: 3.444

Review 5.  The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers.

Authors:  Carla J Ramos; David A Antonetti
Journal:  Tissue Barriers       Date:  2017-06-09

6.  Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.

Authors:  Zhen Li; Yun-hui Liu; Yi-xue Xue; Li-bo Liu; Ping Wang
Journal:  J Mol Neurosci       Date:  2013-10-25       Impact factor: 3.444

7.  Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.

Authors:  Zhen Li; Yun-hui Liu; Yi-xue Xue; Li-bo Liu; Hui Xie
Journal:  J Mol Neurosci       Date:  2011-10-04       Impact factor: 3.444

8.  Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.

Authors:  Zhen Li; Xiao-bai Liu; Yun-hui Liu; Yi-xue Xue; Jing Liu; Hao Teng; Zhuo Xi; Yi-long Yao
Journal:  J Mol Neurosci       Date:  2015-09-10       Impact factor: 3.444

9.  Rho GEFs in endothelial junctions: Effector selectivity and signaling integration determine junctional response.

Authors:  Siu P Ngok; Panos Z Anastasiadis
Journal:  Tissue Barriers       Date:  2013-11-15

10.  Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells.

Authors:  Yan-feng Wang; Yan-ting Gu; Guang-hua Qin; Lei Zhong; Ying-nan Meng
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.